Savara Pharmaceuticals is a privately funded company. Savara has also received funding and grants from the Texas Emerging Technology Fund, Qualifying Therapeutic Discovery Program, The National Institute for Allergies and Infectious Diseases and the National Institute of Health.

We are interested in establishing relationships with venture capital and private equity partners. If interested, please contact Rob Neville at .